glutamic acid has been researched along with humulene in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 8 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Piomelli, D | 1 |
| Choi, YH; Erkelens, C; Hazekamp, A; Kim, HK; Lefeber, AW; Verpoorte, R | 1 |
| Arai, S; Blaber, M; Kurihara, K; Kuroki, R; Morimoto, S; Shoyama, Y; Takeuchi, A; Tamada, T; Taura, F | 1 |
| Gururajan, A; Klug, M; Manning, EE; van den Buuse, M | 1 |
| Blokland, A; de Sousa Fernandes Perna, EB; Heckman, P; Kuypers, KP; Prickaerts, J; Ramaekers, JG; Sambeth, A; Theunissen, EL; Toennes, SW | 1 |
| Bhattacharyya, S; Colizzi, M; McGuire, P; Pertwee, RG | 1 |
| Cheng, H; Dharmadhikari, S; Dydak, U; Hetrick, W; Kim, DJ; Newman, SD; O'Donnell, B; Schnakenberg-Martin, A | 1 |
| Bhattacharyya, S; Blest-Hopley, G; Egerton, A; Giampietro, V; Lythgoe, D; O'Neill, A; Wilson, R | 1 |
| Annibale, L; Bhattacharyya, S; Colizzi, M; Collier, T; Das, D; Eranti, S; Kelbrick, M; Kempton, MJ; Lythgoe, D; McGuire, P; O'Neill, A; Onyejiaka, C; Sami, M; Williams, SCR; Worker, A | 1 |
| Dahlgren, MK; Davis, KA; Fitzmaurice, GM; Gruber, S; Kuppe, MK; Lukas, SE; Zuo, CS | 1 |
| McGlade, E; Prescot, A; Renshaw, P; Subramaniam, P; Yurgelun-Todd, D | 1 |
| Davis, KA; Lukas, SE; Zuo, CS | 1 |
| Barnes, S; Cheng, H; Newman, SD; O'Donnell, BF; Raymond, D; Schnakenberg Martin, AM; Wilson, L | 1 |
| Biagi, M; Borgonetti, V; Galeotti, N; Governa, P; Manetti, F | 1 |
3 review(s) available for glutamic acid and humulene
| Article | Year |
|---|---|
The molecular logic of endocannabinoid signalling.
Topics: Animals; Cannabinoid Receptor Modulators; Cannabis; Dronabinol; Endocannabinoids; gamma-Aminobutyric Acid; Glutamic Acid; Hallucinogens; Humans; Neurotransmitter Agents; Receptor, Cannabinoid, CB1; Signal Transduction; Synaptic Transmission | 2003 |
Drugs of abuse and increased risk of psychosis development.
Topics: Age of Onset; Animals; Behavioral Symptoms; Brain; Cannabis; Dopamine; Dopamine Uptake Inhibitors; Functional Neuroimaging; Genetic Predisposition to Disease; Glutamic Acid; Humans; Illicit Drugs; Methamphetamine; Models, Animal; Psychoses, Substance-Induced; Risk Factors; Schizophrenia; Substance-Related Disorders | 2012 |
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence.
Topics: Animals; Brain; Cannabis; Dronabinol; Excitatory Amino Acid Agents; Glutamic Acid; Humans | 2016 |
1 trial(s) available for glutamic acid and humulene
| Article | Year |
|---|---|
Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans.
Topics: Acetylcholine; Adult; Attention; Cannabinoids; Cannabis; Cognition; Cross-Over Studies; Double-Blind Method; Female; Glutamic Acid; Humans; Imidazoles; Male; Marijuana Smoking; Memory; Memory Disorders; Memory, Short-Term; Phenylcarbamates; Piperazines; Prospective Studies; Rivastigmine; Sulfones; Triazines; Vardenafil Dihydrochloride; Verbal Learning; Young Adult | 2015 |
10 other study(ies) available for glutamic acid and humulene
| Article | Year |
|---|---|
Metabolomic differentiation of Cannabis sativa cultivars using 1H NMR spectroscopy and principal component analysis.
Topics: Asparagine; Cannabinoids; Cannabis; Dronabinol; Flowers; Glucose; Glutamic Acid; Magnetic Resonance Spectroscopy; Molecular Structure; Netherlands; Nuclear Magnetic Resonance, Biomolecular; Plant Leaves; Plants, Medicinal; Principal Component Analysis; Sucrose | 2004 |
Structure and function of ∆1-tetrahydrocannabinolic acid (THCA) synthase, the enzyme controlling the psychoactivity of Cannabis sativa.
Topics: Animals; Berberine; Cannabis; Carbon Dioxide; Crystallography, X-Ray; Cysteine; Flavin-Adenine Dinucleotide; Glutamic Acid; Histidine; Intramolecular Oxidoreductases; Mutation; Protein Structure, Tertiary; Psychotropic Drugs; Structure-Activity Relationship; Tyrosine | 2012 |
An investigation of the relationship between glutamate and resting state connectivity in chronic cannabis users.
Topics: Cannabis; Female; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Marijuana Smoking; Rest; Young Adult | 2020 |
Adolescent-onset heavy cannabis use associated with significantly reduced glial but not neuronal markers and glutamate levels in the hippocampus.
Topics: Adult; Alcohol Oxidoreductases; Aspartic Acid; Biomarkers; Cannabis; Female; Glutamic Acid; Hippocampus; Humans; Inositol; Male; Marijuana Abuse; Neuroglia; Neurons; Young Adult | 2020 |
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis.
Topics: Cannabis; Carcinoma, Hepatocellular; Glutamic Acid; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Psychotic Disorders | 2020 |
Elevated striatal glutamate + glutamine in recreational cannabis users during abstinence.
Topics: Cannabis; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Hallucinogens; Humans; Substance Withdrawal Syndrome | 2022 |
Examination of gamma-aminobutyric acid and glutamate-glutamine levels in association with impulsive behavior in adolescent marijuana users.
Topics: Adolescent; Cannabis; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Impulsive Behavior; Magnetic Resonance Spectroscopy; Substance-Related Disorders | 2022 |
Lower dACC glutamate in cannabis users during early phase abstinence.
Topics: Cannabinoid Receptor Agonists; Cannabis; Dronabinol; gamma-Aminobutyric Acid; Glutamic Acid; Gyrus Cinguli; Hallucinogens; Humans; Protons; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome | 2022 |
The relationship between cannabis use and taurine: A MRS and metabolomics study.
Topics: Analgesics; Cannabinoid Receptor Agonists; Cannabis; Glutamic Acid; Hallucinogens; Humans; Magnetic Resonance Spectroscopy; Metabolomics; Taurine | 2022 |
Investigation on the neuroprotective effect of a cannabidiol-enriched non-psychotropic Cannabis sativa L. extract in an in vitro model of excitotoxicity.
Topics: Brain-Derived Neurotrophic Factor; Cannabidiol; Cannabis; Glutamic Acid; Humans; Molecular Structure; Neuroblastoma; Neuroprotective Agents; Plant Extracts | 2022 |